GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » EV-to-Revenue

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) EV-to-Revenue : 1.44 (As of May. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Integrated Diagnostics Holdings's enterprise value is $196.8 Mil. Integrated Diagnostics Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $137.0 Mil. Therefore, Integrated Diagnostics Holdings's EV-to-Revenue for today is 1.44.

The historical rank and industry rank for Integrated Diagnostics Holdings's EV-to-Revenue or its related term are showing as below:

IDGXF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.97   Med: 1.95   Max: 21.45
Current: 1.44

During the past 12 years, the highest EV-to-Revenue of Integrated Diagnostics Holdings was 21.45. The lowest was 0.97. And the median was 1.95.

IDGXF's EV-to-Revenue is ranked better than
74.67% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.04 vs IDGXF: 1.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), Integrated Diagnostics Holdings's stock price is $0.296. Integrated Diagnostics Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.23. Therefore, Integrated Diagnostics Holdings's PS Ratio for today is 1.29.


Integrated Diagnostics Holdings EV-to-Revenue Historical Data

The historical data trend for Integrated Diagnostics Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings EV-to-Revenue Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.31 3.84 2.07 2.78 1.70

Integrated Diagnostics Holdings Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.75 2.78 1.82 2.06 -

Competitive Comparison of Integrated Diagnostics Holdings's EV-to-Revenue

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's EV-to-Revenue falls into.



Integrated Diagnostics Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Integrated Diagnostics Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=196.843/137.016
=1.44

Integrated Diagnostics Holdings's current Enterprise Value is $196.8 Mil.
Integrated Diagnostics Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $137.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrated Diagnostics Holdings  (OTCPK:IDGXF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Integrated Diagnostics Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.296/0.229
=1.29

Integrated Diagnostics Holdings's share price for today is $0.296.
Integrated Diagnostics Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrated Diagnostics Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021